U. Daum

Multiple dysfunctions of two apolipoprotein A-I variants, apoA-I(R160L)Oslo and apoA-I(P165R), that are associated with hypoalphalipoproteinemia in heterozygous carriers.

A. von Eckardstein, G. Assmann, P. Cullen, 1999, Journal of lipid research.

Apolipoprotein A-I(R151C)Paris is defective in activation of lecithin:cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux

A. von Eckardstein, G. Assmann, P. Cullen, 1999, Journal of Molecular Medicine.

Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I.

A. von Eckardstein, G. Assmann, K. Berg, 1997, Journal of lipid research.

A natural apolipoprotein A-I variant, apoA-I (L141R)Pisa, interferes with the formation of alpha-high density lipoproteins (HDL) but not with the formation of pre beta 1-HDL and influences efflux of cholesterol into plasma.

A. von Eckardstein, G. Assmann, R. Navalesi, 1997, Journal of lipid research.